MedTrace Logo

WiCS-LV Post Market Surveillance Registry

NCT02610673 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-03-21

No results posted yet for this study

Summary

This is an observational, prospective, non-randomized collection of defined clinical data under normal conditions of use for the WiCS-LV System, an implantable cardiac pacing system capable of delivering pacing energy to the left ventricle of the heart without using a pacing lead.

Patients will be enrolled and followed according to standard of care for 5 years.

Conditions

  • Cardiac Resynchronization Therapy

Interventions

DEVICE

WiCS-LV System

Implant of left ventricular receiver-electrode and ultrasound transmitter.

Sponsors & Collaborators

  • EBR Systems, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-08
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • Denmark
  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02610673 on ClinicalTrials.gov